Advertisement
UK markets close in 3 hours 17 minutes

  • FTSE 100

    8,096.42
    +56.04 (+0.70%)
     

  • FTSE 250

    19,729.27
    +9.90 (+0.05%)
     

  • AIM

    755.36
    +0.67 (+0.09%)
     

  • GBP/EUR

    1.1672
    +0.0027 (+0.23%)
     

  • GBP/USD

    1.2511
    +0.0049 (+0.39%)
     

  • Bitcoin GBP

    51,236.49
    -2,049.01 (-3.85%)
     

  • CMC Crypto 200

    1,358.07
    -24.51 (-1.77%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CRUDE OIL

    83.09
    +0.28 (+0.34%)
     

  • GOLD FUTURES

    2,341.80
    +3.40 (+0.15%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,998.66
    -90.04 (-0.50%)
     

  • CAC 40

    8,030.41
    -61.45 (-0.76%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Why Liquidia Stock Rocketed Nearly 21% Higher Today

Eric Volkman, The Motley Fool
·2-min read

One of the more volatile healthcare stocks of recent days, Liquidia Technologies (NASDAQ: LQDA), had quite the up session on Friday. Investors lifted the share price of the drug developer by almost 21%, following a series of relatively small but confidence-boosting insider buys. Liquidia has been an up-and-down stock due to developments on the legal front, specifically a patent infringement dispute it was engaged in against plaintiff United Therapeutics (NASDAQ: UTHR).

Continue reading